25 Aug SAHPRA Earns a Regulatory Accolade of Note
SAHPRA has been designated as a Regional Centre of Regulatory Excellence (RCORE) for Vaccines Regulatory Oversight for a period of four (4) years....
SAHPRA has been designated as a Regional Centre of Regulatory Excellence (RCORE) for Vaccines Regulatory Oversight for a period of four (4) years....
Pretoria, 10 August 2023 – The Africa Centre for Disease Control and Prevention (Africa CDC) has today officially handed over equipment worth USD 750,000 to South African Health Products Regulatory Authority (SAHPRA) to support its regulatory functions relating specifically to vaccine manufacturing. In April 2021, the...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African...
Pretoria, 11 July 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA) on 09 July at the Egyptian Embassy in Pretoria. This MOU between SAHPRA and EDA will allow for crucial collaboration and...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African...
Pretoria, 29 May 2023 EF: If you had to design a healthcare initiative or startup, what would it be? BS: There are three critical needs, that could be addressed at a very national level. Finding a way of partnering between the public sector and the private sector to improve the...
Pretoria, 15 May 2023 -The South Africa Health Products Regulatory Authority (SAHPRA) acknowledges and aligns itself to the statement issued by the World Health Organization (WHO) Director-General, declaring an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the...
Pretoria, 21 April 2023 - The South African Health Products Regulatory Authority (SAHPRA) issued media statements on 4 August 2022 and 12September 2022, relating to two fatal cases of Guillain-Barré syndrome (GBS) following vaccination with COVID-19 Vaccine Janssen. SAHPRA has been informed of a third...
Pretoria, 06 April 2023 – The South African Health Products Regulatory Authority (SAHPRA) has made the decision to withdraw pholcodine-containing medicines from the South African (SA) market due to the increased risk of sudden, severe, and life-threatening allergic reactions occurring during surgery. There is a...